EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Update on the management of systemic juvenile idiopathic arthritis and role of IL-1 and IL-6 inhibition

Sriharsha Grevich, Susan Shenoi

Adolescent Health, Medicine and Therapeutics · 2017

DOI: 10.2147/ahmt.s109495 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Adolescent Health, Medicine and Therapeutics, 2017. Verfasst von Sriharsha Grevich und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Seattle Children's Hospital, Seattle, WA, USA. Die Arbeit wurde bisher 43-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

IL-1 inhibitorsIL-6 inhibitorsanakinracanakinumabmacrophage activation syndromesystemic juvenile idiopathic arthritistocilizumab

Autor:innen und Institutionen

  • Department of Rheumatology, Seattle Children's Hospital, Seattle, WA, USA.

Zitieren

APA

Grevich, S., & Shenoi, S. (2017). Update on the management of systemic juvenile idiopathic arthritis and role of IL-1 and IL-6 inhibition. Adolescent Health, Medicine and Therapeutics. https://doi.org/10.2147/ahmt.s109495

Vancouver

Grevich S, Shenoi S. Update on the management of systemic juvenile idiopathic arthritis and role of IL-1 and IL-6 inhibition. Adolescent Health, Medicine and Therapeutics. 2017. doi:10.2147/ahmt.s109495

BibTeX
@article{Grevich2017,
  author = {Grevich, Sriharsha and Shenoi, Susan},
  title = {Update on the management of systemic juvenile idiopathic arthritis and role of IL-1 and IL-6 inhibition},
  journal = {Adolescent Health, Medicine and Therapeutics},
  year = {2017},
  doi = {10.2147/ahmt.s109495}
}
Kostenlos starten →